Sticares InterACT

Office Address:
Oever 1-5
3161 GR Rhoon
The Netherlands

Mailing Address:
P.O. Box 882
3160 AB Rhoon
The Netherlands

KvK nr 24450203

Phone:
+ 31 10 485 5177
Fax:
+ 31 10 501 0733
 
 

Scientific Advisory Board

Sticares InterACT combines its full-service CRO capabilities with the clinical expertise and the academic leadership of the Sticares Cardiovascular Research Institute (SCRI). We offer consulting services through thought leadership of SCRI’s academic body, the Scientific Advisory Board.

The Scientific Advisory Board consists of internationally renowned academic experts who have made breakthroughs in diagnosis, medical therapy, surgical procedures, and clinical research; all with high-level inroads to pharmaceutical companies, accelerating critical time-to-market for our sponsors.
Our own CEO Professor Willem J. Remme complements the Scientific Advisory Board as an expert in heart failure.

DR. GEORGE L. BAKRIS DR. MIHAI GHEORGHIADE DR. ROBERT S. ROSENSON DR. HANI N. SABBAH

George L. Bakris, MD, FAHA, FASN, is Professor of Medicine at the University of Chicago School of Medicine in Illinois, and serves as Director of the Hypertension Center in the Diabetes Institute.
Professor Bakris received his medical degree from the Chicago Medical School. He completed his residency in Internal Medicine at the Mayo Graduate School of Medicine, where he also completed a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago.

Professor Bakris specializes in the diagnosis and reduction of high blood pressure, particularly in complicated or refractory cases. He is also skilled in the treatment of kidney disease, with special expertise in diabetes-related kidney disease. Professor Bakris has published over 400 articles and book chapters in the areas of kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of several books, all dealing with Kidney Diseases, Diabetes and the role of Hypertension. Click here for his publications listed with PubMed.

Dr. Gheorghiade, MD, FACC, FCCP, FACP, is a Professor of Medicine and Surgery, associate chief of the Division of Cardiology, chief of the Cardiology Clinical Service, and director of the Telemetry Unit at Northwestern University's Feinberg School of Medicine. Professor Gheorghiade obtained his MD, Magna Cum Laude, from the University of Rome in 1972 and did his training in internal medicine and cardiology at Brown University.


Professor Gheorghiade’s research interests are related to the pathophysiology, prognosis, and management of hospitalized patients with heart failure and the roles of vasopressin antagonist, newer inotropes, adenosine blocking agents, and other new agents in acute heart failure in heart failure. He is a member of many national and international committees and serves on the editorial board of many journals including the American Heart Journal, The American Journal of Cardiology, The Journal of the American College of Cardiology and Circulation: Heart Failure journal. Professor Gheorghiade is the author of more than 500 publications and more than 300 original presentations at national and international meetings. Click
here for his publications listed with PubMed.

Professor of Medicine and Cardiology Robert S. Rosenson, MD, PhD, FACC, FAHA, currently resides in Professor Fuster’s Mount Sinai Heart at The Mount Sinai Medical Center in New York City.

Before joining Mount Sinai Heart, he was Professor of Medicine and Director of Lipoprotein Disorders and Clinical Atherosclerosis Research & Cardiovascular Diseases at the University of Michigan in Ann Arbor.

His clinical research has investigated the effects of lipid-lowering therapies‚ hypoglycemic therapies and antihypertensive agents on inflammation and thrombogenesis as well as the effects of hyplolipidemic and antihypertensive agents on blood viscosity and fibrinogen. Previously‚ he was Professor of Cardiology at Northwestern University Medical School‚ where he also served as Director of the Preventative Cardiology Center and Director of the Lipoprotein and Hemorheology Research Facility. He has published over 70 peer-reviewed scientific papers and nearly 70 book chapters in the field. He also serves as an editor of a number of journals including Atherosclerosis. Click here for his publications listed with PubMed.

Professor of Cardiology Hani N. Sabbah, MD, PhD, FACC, FAHA, is the current director of the Cardiovascular Research Laboratories at Henry Ford Health System of the Henry Ford Hospital in Detroit.

The Cardiovascular Research Laboratories at Henry Ford Health System function as a multidisciplinary center fully focused on understanding the pathophysiology of heart failure and on the development and testing of novel therapeutic modalities for the treatment of this disease syndrome. Dr. Hani N. Sabbah is tenured Professor of Medicine at Case Western Reserve University in Cleveland, Ohio and tenured Professor of Medicine at Wayne State University in Detroit, Michigan.


He is the author of over 20 book chapters, over 300 peer reviewed publications and over 500 abstract presented at national and international scientific conferences. Dr. Sabbah is member of the editorial board of several peer-reviewed scientific journals and is the Co Editor-in-Chief of the journal Heart Failure Reviews. Click
here for his publications listed with PubMed.

 
Therapeutic Areas | Medical Review | Other Services | News and Events | Resources | Career opportunities | Contact Us | Search history | CRO | Clinical research organisation | Contract Research | Clinical Trial Monitoring | Clinical Study Design and Protocol | Clinical Research Associate | Clinical Project Management | Clinical Data Management | Cardiovascular Research | Pharmacovigilance 2009 © Sticares InterACT
disclaimer